AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute

Sidney C. Smith; Jerilyn Allen; Steven N. Blair; Robert O. Bonow; Lawrence M. Brass; Gregg C. Fonarow; Scott M. Grundy; Loren Hiratzka; Daniel Jones; Harlan M. Krumholz; Lori Mosca; Richard C. Pasternak; Thomas Pearson; Marc A. Pfeffer; Kathryn A. Taubert

doi:10.1016/j.jacc.2006.04.026

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute

Sidney C. Smith, Jerilyn Allen, Steven N. Blair, Robert O. Bonow, Lawrence M. Brass, Gregg C. Fonarow, Scott M. Grundy, Loren Hiratzka, Daniel Jones, Harlan M. Krumholz, Lori Mosca, Richard C. Pasternak, Thomas Pearson, Marc A. Pfeffer, Kathryn A. Taubert

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	2130-2139
Number of pages	10
Journal	Journal of the American College of Cardiology
Volume	47
Issue number	10
DOIs	https://doi.org/10.1016/j.jacc.2006.04.026
State	Published - May 16 2006
Externally published	Yes

Keywords

AHA Scientific Statements
coronary disease
prevention
risk factors
vascular diseases

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2006.04.026

Cite this

Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., Mosca, L., Pasternak, R. C., Pearson, T., Pfeffer, M. A., & Taubert, K. A. (2006). AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute. Journal of the American College of Cardiology, 47(10), 2130-2139. https://doi.org/10.1016/j.jacc.2006.04.026

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease : 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute. / Smith, Sidney C.; Allen, Jerilyn; Blair, Steven N.; Bonow, Robert O.; Brass, Lawrence M.; Fonarow, Gregg C.; Grundy, Scott M.; Hiratzka, Loren; Jones, Daniel; Krumholz, Harlan M.; Mosca, Lori; Pasternak, Richard C.; Pearson, Thomas; Pfeffer, Marc A.; Taubert, Kathryn A.

In: Journal of the American College of Cardiology, Vol. 47, No. 10, 16.05.2006, p. 2130-2139.

Research output: Contribution to journal › Review article › peer-review

Smith, SC, Allen, J, Blair, SN, Bonow, RO, Brass, LM, Fonarow, GC, Grundy, SM, Hiratzka, L, Jones, D, Krumholz, HM, Mosca, L, Pasternak, RC, Pearson, T, Pfeffer, MA & Taubert, KA 2006, 'AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute', Journal of the American College of Cardiology, vol. 47, no. 10, pp. 2130-2139. https://doi.org/10.1016/j.jacc.2006.04.026

Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC et al. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute. Journal of the American College of Cardiology. 2006 May 16;47(10):2130-2139. https://doi.org/10.1016/j.jacc.2006.04.026

Smith, Sidney C. ; Allen, Jerilyn ; Blair, Steven N. ; Bonow, Robert O. ; Brass, Lawrence M. ; Fonarow, Gregg C. ; Grundy, Scott M. ; Hiratzka, Loren ; Jones, Daniel ; Krumholz, Harlan M. ; Mosca, Lori ; Pasternak, Richard C. ; Pearson, Thomas ; Pfeffer, Marc A. ; Taubert, Kathryn A. / AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease : 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute. In: Journal of the American College of Cardiology. 2006 ; Vol. 47, No. 10. pp. 2130-2139.

@article{d98e5250e879439fa6de6ef991a17380,

title = "AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute",

keywords = "AHA Scientific Statements, coronary disease, prevention, risk factors, vascular diseases",

author = "Smith, {Sidney C.} and Jerilyn Allen and Blair, {Steven N.} and Bonow, {Robert O.} and Brass, {Lawrence M.} and Fonarow, {Gregg C.} and Grundy, {Scott M.} and Loren Hiratzka and Daniel Jones and Krumholz, {Harlan M.} and Lori Mosca and Pasternak, {Richard C.} and Thomas Pearson and Pfeffer, {Marc A.} and Taubert, {Kathryn A.}",

note = "Funding Information: Reviewers{\textquoteright} Disclosures Reviewer Employment Research Grant Other Research Support Speakers Bureau/Honoraria Ownership Interest Consultant/Advisory Board Other Jonathan Abrams, MD University of New Mexico Health Science Center None None None None None None Joseph Alpert, MD University of Arizona Department of Medicine None None None None None None Jeffrey L. Anderson, MD LDS Hospital Cardiology Bristol-Myers Squibb (grant pending) None Bristol-Myers Squibb, Dia Dexus, Guilford, Merck, Johnson&Johnson/Merck, Merck-Schering, Sanofi-Aventis None Bristol-Myers Squibb, Guilford, Merck, Johnson&Johnson/Merck, Merck-Schering None Eric R. Bates, MD University of Michigan Medical Center None None None None None None Vera Bittner, MD University of Alabama at Birmingham NHLBI, Pfizer, AtheroGenics None Pfizer, Merck, Kos, Reliant None CV Therapeutics, Reliant None Ann Bolger, MD University of California San Francisco None None None None None None Roger S. Blumenthal, MD Johns Hopkins Hospital Merck, Pfizer None Pfizer, Merck, Astra Zeneca, Kos, Schering-Plough None None None Prakash Deedwania, MD University of California San Francisco Pfizer, AstraZeneca None None None Pfizer, AstraZeneca, Novartis None Mark J. Eisenberg, MD McGill University None None None None None None Gerald Fletcher, MD Mayo Clinic None None None None None None Alan D. Forker, MD St. Lukes Hospital Pfizer, Merck, Kos, Novartis, Sankyo, Bristol-Myers Squibb None Pfizer, Merck, Takeda None None None Timothy Gardner, MD Clinical Practices of the University of Pennsylvania None None None None None None Cindy L. Grines, MD William Beaumont Hospital Berlex, Pfizer, GlaxoSmithKline, Aventis, Guidant Eli Lilly, SCIMED, Johnson&Johnson, Amersham Health, Otsuka, Esperion Therapeutics, Innercool Therapies, AstraZeneca None None None Innercool Therapies, Pfizer, Sanofi-Synthelabo, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline Global Cardiovascular Advisory Board None Suzanne Hughes, MSN, RN None None Kos Pharmaceuticals None Guidant Corporation, Johnson&Johnson Merck Freelance writer—honoraria paid by the ACCF; Associate Editor, Cardiosource None Edgar J. Kenton, MD Lankenau Hospital None None None None None None Marian Limacher, MD University of Florida Boehringer Ingelheim NIH, NHLBI Kos Pharmaceuticals None NIH Advisory Committee on Research on Women{\textquoteright}s Health None Jonathan R. Lindner, MD University of Virginia None None None None None None Janet B. Long, MSN, ACNP University Cardiology Foundation None None AstraZeneca None None None Patrick McBride, MD University of Wisconsin Medical School None None Kos, Merck, Pfizer, Sanyko, Schering Plough None Merck None Dale Owen, MD None None None None None None None Rita F. Redberg, MD, MSc None None None None None None None Samuel J. Shubrooks, Jr, MD Harvard Medical School None None None None None None Robert A. Vogel, MD University of Maryland Hospital Pfizer, Novartis, Schering-Plough None Pfizer, Merck None None None ",

year = "2006",

month = may,

day = "16",

doi = "10.1016/j.jacc.2006.04.026",

language = "English (US)",

volume = "47",

pages = "2130--2139",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "10",

}

TY - JOUR

T1 - AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease

T2 - 2006 Update. Endorsed by the National Heart, Lung, and Blood Institute

AU - Smith, Sidney C.

AU - Allen, Jerilyn

AU - Blair, Steven N.

AU - Bonow, Robert O.

AU - Brass, Lawrence M.

AU - Fonarow, Gregg C.

AU - Grundy, Scott M.

AU - Hiratzka, Loren

AU - Jones, Daniel

AU - Krumholz, Harlan M.

AU - Mosca, Lori

AU - Pasternak, Richard C.

AU - Pearson, Thomas

AU - Pfeffer, Marc A.

AU - Taubert, Kathryn A.

N1 - Funding Information: Reviewers’ Disclosures Reviewer Employment Research Grant Other Research Support Speakers Bureau/Honoraria Ownership Interest Consultant/Advisory Board Other Jonathan Abrams, MD University of New Mexico Health Science Center None None None None None None Joseph Alpert, MD University of Arizona Department of Medicine None None None None None None Jeffrey L. Anderson, MD LDS Hospital Cardiology Bristol-Myers Squibb (grant pending) None Bristol-Myers Squibb, Dia Dexus, Guilford, Merck, Johnson&Johnson/Merck, Merck-Schering, Sanofi-Aventis None Bristol-Myers Squibb, Guilford, Merck, Johnson&Johnson/Merck, Merck-Schering None Eric R. Bates, MD University of Michigan Medical Center None None None None None None Vera Bittner, MD University of Alabama at Birmingham NHLBI, Pfizer, AtheroGenics None Pfizer, Merck, Kos, Reliant None CV Therapeutics, Reliant None Ann Bolger, MD University of California San Francisco None None None None None None Roger S. Blumenthal, MD Johns Hopkins Hospital Merck, Pfizer None Pfizer, Merck, Astra Zeneca, Kos, Schering-Plough None None None Prakash Deedwania, MD University of California San Francisco Pfizer, AstraZeneca None None None Pfizer, AstraZeneca, Novartis None Mark J. Eisenberg, MD McGill University None None None None None None Gerald Fletcher, MD Mayo Clinic None None None None None None Alan D. Forker, MD St. Lukes Hospital Pfizer, Merck, Kos, Novartis, Sankyo, Bristol-Myers Squibb None Pfizer, Merck, Takeda None None None Timothy Gardner, MD Clinical Practices of the University of Pennsylvania None None None None None None Cindy L. Grines, MD William Beaumont Hospital Berlex, Pfizer, GlaxoSmithKline, Aventis, Guidant Eli Lilly, SCIMED, Johnson&Johnson, Amersham Health, Otsuka, Esperion Therapeutics, Innercool Therapies, AstraZeneca None None None Innercool Therapies, Pfizer, Sanofi-Synthelabo, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline Global Cardiovascular Advisory Board None Suzanne Hughes, MSN, RN None None Kos Pharmaceuticals None Guidant Corporation, Johnson&Johnson Merck Freelance writer—honoraria paid by the ACCF; Associate Editor, Cardiosource None Edgar J. Kenton, MD Lankenau Hospital None None None None None None Marian Limacher, MD University of Florida Boehringer Ingelheim NIH, NHLBI Kos Pharmaceuticals None NIH Advisory Committee on Research on Women’s Health None Jonathan R. Lindner, MD University of Virginia None None None None None None Janet B. Long, MSN, ACNP University Cardiology Foundation None None AstraZeneca None None None Patrick McBride, MD University of Wisconsin Medical School None None Kos, Merck, Pfizer, Sanyko, Schering Plough None Merck None Dale Owen, MD None None None None None None None Rita F. Redberg, MD, MSc None None None None None None None Samuel J. Shubrooks, Jr, MD Harvard Medical School None None None None None None Robert A. Vogel, MD University of Maryland Hospital Pfizer, Novartis, Schering-Plough None Pfizer, Merck None None None

PY - 2006/5/16

Y1 - 2006/5/16

KW - AHA Scientific Statements

KW - coronary disease

KW - prevention

KW - risk factors

KW - vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=33646828142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646828142&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2006.04.026

DO - 10.1016/j.jacc.2006.04.026

M3 - Review article

C2 - 16697342

AN - SCOPUS:33646828142

VL - 47

SP - 2130

EP - 2139

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10

ER -